Back to search

Article

Whether, when, how, and how much? General public’s and cancer patients’ views about the disclosure of genomic secondary findings

2021-02-23

Abstract excerpt

<h4>Background: </h4> Data on the modalities of disclosing genomic secondary findings (SFs) remain scarce. We explore cancer patients’ and the general public’s perspectives about disclosing genomic SFs and the modalities of such disclosure. <h4>Methods: </h4> Sixty-one cancer patients (n=29) and members of the public (n=32) participated in eight focus groups in Montreal and Quebec City, Canada. They were asked to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
226622cb-9e71-5c33-beea-8622b9d99902
DOI
10.21203/rs.3.rs-220910/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Whether, when, how, and how much? General public’s and cancer patients’ views about the disclosure of genomic secondary findingsDOI 10.21203/rs.3.rs-220910/v1
Select a neighboring publication to make it the new centre.